Loading organizations...
§ Venture Capital · London, England, United Kingdom
Holding company supporting entrepreneurial activities for businesses across medical, energy, information, finance, and media sectors
Animatrix Capital invests in early-stage companies featuring innovative, disruptive concepts. This private investment vehicle provides capital and strategic guidance to ventures spanning diverse sectors, including health, education, alternative energy, leisure, and media. The firm’s approach encompasses financial backing and active participation in developing numerous startups, demonstrating a hands-on model to cultivate market-changing businesses.
Rupert Lywood and Stuart Lawson co-founded the firm, officially launching as Animatrix Founders LLP in July 2009. Their foundational insight centered on identifying and nurturing individuals and teams with extraordinary ideas capable of impacting established markets. Lywood and Lawson prioritize active support beyond capital, guiding portfolio companies through growth and strategic direction.
Animatrix Capital serves entrepreneurs and nascent companies poised to challenge existing paradigms with novel solutions. The firm’s long-term vision is to consistently empower the next generation of market disruptors, driving innovation and growth across diverse industries. They aim to build a portfolio of companies that redefine their fields.
Animatrix Capital has 2 tracked investments across 1 company. The latest tracked deal is $33.0M Series A in Centauri Therapeutics in February 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Feb 1, 2022 | Centauri Therapeutics | $33.0M Series A | — | Boehringer Ingelheim Venture Fund, Johannes Zanzinger, Karen Lackey, Kent Life Science, Camilla Petrycer Hansen, Wren Capital |
| Jan 18, 2016 | Centauri Therapeutics | $4.3M Seed | — | — |